Ads
related to: medicare part d
Search results
As pharmacies disappear nationwide, Oregonians among the hardest hit
OregonLive.com· 2 days agoBrooklyn Pharmacy in Southeast Portland is a throwback to the days of mom-and-pop neighborhood...
Doctors' Tips for Accessing Costly GLP-1 Therapies
Medscape· 2 days ago"Does your insurance cover anti-obesity drugs?" Laura Davisson, MD, once again asked the patient before her. While glucagon-like peptide 1 (GLP-1)...
Ozempic and Wegovy Are Fueling Novo Nordisk's Business, but Something Else May Be an Even Bigger...
The Motley Fool via AOL· 3 days ago(FDA). Specifically, Wegovy was granted an expanded indication to treat patients at risk of heart...
Ozempic and Wegovy Are Fueling Novo Nordisk's Business, but Something Else May Be an Even Bigger...
The Motley Fool· 3 days agoOver the last few years, some of the best-performing stocks in the broader healthcare space have...
Medicare Plan Pay Confusion Could Wreck 2025 Enrollment, Lawsuits Warn | ThinkAdvisor
ThinkAdvisor· 2 days agoMedicare plan agents, brokers, distributors and trade groups are asking the federal courts to block...
Medicare drug plans are slashing drug coverage — and it’s going to impact everyone
MarketWatch via Yahoo Finance· 6 days agoIn many cases, where people are shunted onto a drug that doesn’t work for them, they end up going...
Older Americans hit hard by Biden’s Medicare funny business
The Washington Times· 2 days agoThe federal legislation, signed into law in 2022, flips Medicare Part D upside down by empowering...
Millions of Americans need drugs like Ozempic: Will it bankrupt the health care system?
Medical Xpress· 5 days agoAn April 24 letter from Vermont Sen. Bernie Sanders to the CEO of Novo Nordisk began with heartfelt...
Study Raises Concerns About Rising Cost of Diabetes Meds
Medscape· 5 days agoDriven by payments for diabetes treatments — especially insulin — prescription drugs for metabolic...
Amarin's Vascepa to Be Dropped From Coverage by National Pharmacy Benefit Manager
Market Watch· 1 day agoThe PBM said it will be transitioning Vascepa to not covered as of July 1. Currently, Vascepa's volume through these formularies represents about 25% of U.S. prescription volume. Amarin said ...